• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Cardiac Tamponade (2226); Cardiac Perforation (2513); Pericardial Effusion (3271); Thrombosis/Thrombus (4440)
Event Date 11/02/2023
Event Type  Injury  
Event Description
It was reported that a versacross connect was selected for use during a watchman procedure.The right groin femoral access was successful.The transseptal - interatrial septum was achieved using the verascross connect.The versacross rf wire was placed in the left upper pulmonary vein (lupv).A non-boston scientific pigtail was advanced over the versacross rf wire, which was then removed, and a contrast injection did not illuminate the appendage.Instead, it looked like it was going through the appendage.The patient was checked for an effusion and a large pericardial effusion (pe) was noted on the right ventricle (rv).Thus, a 100 mg of protamine was given, and a pericardiocentesis was done with 1400 cc of blood removed.The blood then started to clot, and a large clot formed causing a tamponade.Cardiopulmonary resuscitation (cpr) was started and a return of spontaneous circulation (rosc) was achieved.Cardiothoracic (ct) surgery was called and noted a clot in the pericardial space which they decided to surgically remove.The patient was sent to the operation room (or).An additional surgery was performed to fix the cardiac tamponade, that occurred as a result of protamine being given after the effusion was discovered.Blood loss occurred, and a blood transfusion was done.The procedure was cancelled, and the patient was admitted to the intensive care unit for four days.However, the patient then coded and passed away.No issues with the versacross connect were reported.It appeared like a very straight forward case.It was tried to go transseptal once, it was buzzed at the fat part of the septum and did not cross, then it was positioned to the inferior portion of the septum and crossed without difficulty.Perforation could not be estimated when happened.In the physician's opinion, the device contributed to the adverse event.The effusion likely occurred during transseptal puncture which was required for this procedure.No pe was noted prior to the procedure.The device is not expected to be returned for analysis.The was entry into the laa (left atrium appendage), but not deployed/implanted.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18161261
MDR Text Key328418602
Report Number2124215-2023-64776
Device Sequence Number1
Product Code DRE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/02/2023
Initial Date FDA Received11/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Death; Life Threatening; Hospitalization;
Patient Age78 YR
Patient SexMale
Patient RaceWhite
-
-